Navigation Links
China Agro-Technology Appoints New CEO
Date:1/31/2008

SINGAPORE, Jan. 31 /PRNewswire-FirstCall/ -- China Agro-Technology Holdings Ltd ("CAT") today announced that it has appointed Mr. Jorge Cantonnet to be its Chief Executive Officer, replacing interim CEO Harry He, effective as of 1 February 2008. Mr. Cantonnet is based in New York.

CAT is a leading agro-biotechnology company listed on OTCBB in Dec 2007 (OTC Bulletin Board: CAGTF). The company reported total audited revenues of US$37 million in fiscal year ended 30 September 2007, with gross profits of US$35 million and net income of US$32 million. CAT promotes ecologically sustainable technology to meet the global demands for biofuel supply and helps address environmental needs.

Mr. Cantonnet is a financial industry professional with over 25 years of experience. He is a founder and Chairman of the Board of Brazil Ethanol, Inc., a company incorporated to act as an acquisition vehicle for the consolidation of the ethanol industry in Brazil. In March 2007 Mr. Cantonnet led Brazil Ethanol's executive team in its successful completion of a US$150 million equity offering.

"I am thrilled to take on the role of CEO and come on board when the organization is at this stage with exciting developments ahead," said Mr. Cantonnet. "I am confident we will grow from strength to strength, and I am determined to lead the company to continued growth and value creation."

Mr Jorge Cantonnet

Chief Executive Officer

China Agro-Technology Holdings Ltd

Biography

Mr. Jorge Cantonnet is a founding member and Chairman of the Board of Brazil Ethanol, Inc., a company incorporated to act as an acquisition vehicle for the consolidation of the ethanol industry in Brazil. In March 2007 Mr. Cantonnet led Brazil Ethanol's executive team in its successful completion of a US$ 150 million equity offering. He is also the founder of Global Capital Networks, LLC, a principal investment firm focusing in alternative energy industries, and has been its Chairman of the Board from February 2005 until the present day.

Mr. Cantonnet is a financial industry professional with 25 years of experience. From May 1998 until January 2005, he was a Senior Managing Director for Bear Stearns & Co., Inc., where he was the Global Head of Emerging Markets -- Capital Markets with worldwide responsibility for the regions of Latin America, Eastern Europe, Middle East, Africa and Asia. His prior experience includes serving as the co-head of UBS International's Capital Markets business, with responsibility for the region of Latin America, and as an executive with each of Bankers Trust, Merrill Lynch, and Citigroup. Mr. Cantonnet has also served as a director of Progressive Capital Solutions, LLC, a life settlements industry provider, since October 2005 until the present day.

Mr. Cantonnet earned a B.S. degree in Biomedical Engineering from Boston University in 1979 and an M.B.A. degree from Harvard Business School in 1986.

About China Agro-Technology Holdings Ltd

China Agro-Technology Holdings Ltd ("CAT") is an ecologically sustainable agricultural technology enterprise that aims at promoting a global reforestation program, generating environmental rehabilitation and serving the acute demands for paper products.

CAT is primarily involved in the ownership, management and operation of Genetically Engineered plantations, the non-tube clone plantations and the marketing of the proprietary rights and technological know-how to the global market.

CAT's strength is its group of highly innovative research scientists and agronomists who specialize in the R&D of agriculture and intelligent computer non-tube plant propagation technology. Driven by agro-biotechnology, CAT is able to achieve higher output with a shorter growth period. CAT's Genetically Engineered Eucalypt Trees (GEET) strains are suitable for cultivation at different climatic conditions and are able to grow within just 4-5 years time to a height of 35 to 40 meters, as compared to other species that take about 6 to 8 years. Its cutting-edge Non-tube Leaf Culture Technology is able to produce 60 million clone plants in 24 months for 20,000 ha of land from only one nursery station.

The company's trees also yield 50% more in wood timber, about 150 cubic meters per hectare as compared to 100 cubic meters per hectare for those which currently lead the world in eucalyptus production.

Other unique features of CAT's GEETs include increased resistance against pests and weeds, the ability to flourish under adverse weather and soil conditions, reduced usage of agro-chemical and growth of at least 8 rotations over a period of 50 years without the need for replanting of new saplings.


'/>"/>
SOURCE China Agro-Technology
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Historic Breakthrough in Fighting Childrens Batten Disease as China Stem Cells Give New Lease on Life to 6 Year Old California Boy
2. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
3. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
4. AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
5. PPD Expands Global Central Lab Services into China
6. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
7. China Biologic Products Gains Financial Support from Shandong Provincial Government on the Improvement of Production Facilities
8. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
9. Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
10. China Medical Technologies Completes Acquisition of BBE
11. Three Steps to Boost Asymchems Investment in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
Breaking Biology Technology:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
Breaking Biology News(10 mins):